We proceeded to evaluate the clinical relevance of our experimental observation by examining the expression of miR-224 and SMAD4 in the tumor and paired adjacent non-tumorous tissues from 100 HCC patients. This evidence concerns the gene SMAD4 and hepatocellular carcinoma.